a) Turmeric
b) Ginger extract
c) Glucosamine
d) Chondroitin
e) Vitamin D
The Oral/ Dietary Supplements recommendation has been downgraded two levels because of inconsistency and need for additional clarity of efficacy.
The majority of 6 high quality trials (Reginster 2001, Cibere 2004, McAlindon 2004, Clegg 2006, Herrero-Beaumont 2007, Fransen 2015), the majority of 6 moderate quality trials (Noack 1994, Houpt 1999, Rindone 2000, Pavelka 2002, Giordano 2009, and Shahine 2014), and 1 low quality study that met inclusion criteria showed either improvement or no change in patient outcomes for those with osteoarthritis of the knee when taking glucosamine versus control.
The majority of 8 high quality trials (Fransen 2015, Clegg 2006, Uebelhart 2004, Reginster 2017, Morita 2018, Zegels 2013, Kahan 2009, Rondanelli 2019) and 6 moderate quality trials (Mazieres 2007, Moller 2010, Rondanelli 2019, Bourgeois 1998, Mazieres 2001, Bucsi 1998) that met inclusion criteria showed either improvement or no change in patient outcomes for those with osteoarthritis of the knee when taking chondroitin.
One high quality study (Srivastava 2016) that met inclusion criteria showed that Turmeric extract could be used over control to improve adverse events, function, and pain in patient with osteoarthritis of the knee.
One high study (Zakeri 2011) and one moderate quality study (Altman 2001) that met inclusion criteria showed that ginger extract may be used to improve pain in patients with osteoarthritis of the knee. However, there was no significant difference in function between ginger extract and control.
Three high quality studies (McAlindon 2013, Sanghi 2013, and Jin 2016) and 1 moderate quality study (Arden 2016) that met inclusion criteria showed either improvement or no significant difference in patient outcomes for those with osteoarthritis of the knee between Vitamin D and control.
Benefits/Harms of Implementation
The United States Food and Drug Administration does not hold dietary supplements to the same standards as prescription medication. As a result, variability can exist between producers of dietary supplements. The patient’s medications should be evaluated for potential drug-supplement interactions prior to initiating any dietary supplement.
Outcome Importance
Improvement in the predictability of the treatment effect for specific dietary supplements will either reduce an unnecessary out-of-pocket expense or provide patients with a relatively safe method for reducing pain and improving function in the treatment of mild to moderate osteoarthritis of the knee. Knowing which supplements have evidence-based support for effective treatment will reduce unnecessary out-of-pocket expenses and provide patients with a safe method for reducing pain and improving function in the treatment of mild to moderate osteoarthritis of the knee.
Cost Effectiveness/Resource Utilization
Dietary supplements are typically an out-of-pocket expense not covered by medical insurance. As a result, patients must individually consider the expense associated with utilization of dietary supplements. We did not have the analysis to comment on the cost-benefit ratio of dietary supplements compared to other over the counter or prescription medications.
Acceptability
The limited evidence supporting dietary supplements and out-of-pocket expense associated with their use will limit broader acceptance. For patients without a medication interaction, dietary supplements pose limited physical harm as it is typically difficult to consume a toxic quantity. Therefore, it is believed to be an acceptable means to potentially achieve benefit in the treatment of mild to moderate osteoarthritis of the knee.
Feasibility
Dietary supplements are widely available to patients. The associated out-of-pocket expense is the primary barrier to access.
Future Research
The most important future research will need to provide multiple investigations demonstrating reproducible results illustrating the effectiveness of dietary supplements. Additionally, future research is necessary to determine the appropriate dose, frequency, and duration of treatment with dietary supplements.
- Altman, R. D., Marcussen, K. C. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis & Rheumatism 2001; 11: 2531-8
- Arden, N. K., Cro, S., Sheard, S., Dora, C. J., Bara, A., Tebbs, S. A., Hunter, D. J., James, S., Cooper, C., O'Neill, T. W., Macgregor, A., Birrell, F., Keen, R. The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial. Osteoarthritis and Cartilage 2016; 11: 1858-1866
- Bourgeois, P., Chales, G., Dehais, J., Delcambre, B., Kuntz, J. L., Rozenberg, S. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. Osteoarthritis & Cartilage 1998; 0: 25-30
- Bucsi, L., Poor, G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis & Cartilage 1998; 0: 31-6
- Cibere, J., Kopec, J. A., Thorne, A., Singer, J., Canvin, J., Robinson, D. B., Pope, J., Hong, P., Grant, E., Esdaile, J. M. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis & Rheumatism 2004; 5: 738-45
- Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., Bradley, J. D., Bingham, C. O., Weisman, M. H., Jackson, C. G., et al., Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New England Journal of Medicine 2006; 8: 795â?808
- Fransen, M., Agaliotis, M., Nairn, L., Votrubec, M., Bridgett, L., Su, S., Jan, S., March, L., Edmonds, J., Norton, R., Woodward, M., Day, R., Legs study collaborative group Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Annals of the Rheumatic Diseases 2015; 5: 851-8
- Giordano, N., Fioravanti, A., Papakostas, P., Montella, A., Giorgi, G., Nuti, R. The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial. Current Therapeutic Research, Clinical & Experimental 2009; 3: 185-96
- Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, Blanco FJ, Benito P, Martín-Mola E, Paulino J, Marenco JL, Porto A, Laffon A, Araújo D, Figueroa M, Branco J. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007 Feb;56(2):555-67. doi: 10.1002/art.22371.
- Houpt, J. B., McMillan, R., Wein, C., Paget-Dellio, S. D. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. Journal of Rheumatology 1999; 11: 2423-30
- Jin, X., Jones, G., Cicuttini, F., Wluka, A., Zhu, Z., Han, W., Antony, B., Wang, X., Winzenberg, T., Blizzard, L., Ding, C. Effect of Vitamin D supplementation on Tibial cartilage volume and knee pain among patients with symptomatic knee osteoarthritis: A randomized clinical trial. JAMA - Journal of the American Medical Association 2016; 10: 1005-1013
- Kahan, A., Uebelhart, D., De Vathaire, F., Delmas, P. D., Reginster, J. Y. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism 2009; 2: 524-533
- Mazieres, B., Combe, B., Phan Van, A., Tondut, J., Grynfeltt, M. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. Journal of Rheumatology 2001; 1: 173-81
- Mazieres, B., Hucher, M., Zaim, M., Garnero, P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Annals of the Rheumatic Diseases 2007; 5: 639-45
- Mazieres, B., Hucher, M., Zaim, M., Garnero, P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Annals of the Rheumatic Diseases 2007; 5: 639-45
- McAlindon, T., Formica, M., LaValley, M., Lehmer, M., Kabbara, K. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. 2004; 9: 643-9
- McAlindon, T., LaValley, M., Schneider, E., Nuite, M., Lee, J. Y., Price, L. L., Lo, G., Dawson-Hughes, B. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 2013; 2: 155-62
- Morita, M., Yamada, K., Date, H., Hayakawa, K., Sakurai, H., Yamada, H. Efficacy of Chondroitin Sulfate for Painful Knee Osteoarthritis: A One-Year, Randomized, Double-Blind, Multicenter Clinical Study in Japan. Biological & Pharmaceutical Bulletin 2018; 2: 163-171
- Noack, W., Fischer, M., Forster, K. K., Rovati, L. C., Setnikar, I. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis & Cartilage 1994; 1: 51-9
- Pavelka, K., Gatterova, J., Olejarova, M., Machacek, S., Giacovelli, G., Rovati, L. C. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. 2002; 18: 2113-23
- Reginster, J. Y., Deroisy, R., Rovati, L. C., Lee, R. L., Lejeune, E., Bruyere, O., Giacovelli, G., Henrotin, Y., Dacre, J. E., Gossett, C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 9252: 251-6
- Reginster, J. Y., Deroisy, R., Rovati, L. C., Lee, R. L., Lejeune, E., Bruyere, O., Giacovelli, G., Henrotin, Y., Dacre, J. E., Gossett, C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 9252: 251-6
- Rindone, J. P., Hiller, D., Collacott, E., Nordhaugen, N., Arriola, G. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. 2000; 2: 91-4
- Rondanelli, M., Braschi, V., Gasparri, C., Nichetti, M., Faliva, M. A., Peroni, G., Naso, M., Iannello, G., Spadaccini, D., Miraglia, N., Putignano, P., Alalwan, T. A., Perna, S. Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Nutrients 2019; 9: 29
- Rondanelli, M., Braschi, V., Gasparri, C., Nichetti, M., Faliva, M. A., Peroni, G., Naso, M., Iannello, G., Spadaccini, D., Miraglia, N., Putignano, P., Alalwan, T. A., Perna, S. Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Nutrients 2019; 9: 29
- Sanghi, D., Mishra, A., Sharma, A. C., Singh, A., Natu, S. M., Agarwal, S., Srivastava, R. N. Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clinical Orthopaedics & Related Research 2013; 11: 3556-62
- Shahine, E. M., Elhadidi, A. S. Efficacy of glucosamine sulfate in lowering serum level of interleukin-1β in symptomatic primary knee osteoarthritis: Clinical and laboratory study. Alexandria Journal of Medicine 2014; 2: 159-163
- Srivastava, S., Saksena, A. K., Khattri, S., Kumar, S., Dagur, R. S. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial. Inflammopharmacology 2016; 6: 377-388
- Uebelhart, D., Malaise, M., Marcolongo, R., de Vathaire, F., Piperno, M., Mailleux, E., Fioravanti, A., Matoso, L., Vignon, E. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis & Cartilage 2004; 4: 269-76
- Zakeri, Z., Izadi, S., Bari, Z., Soltani, F., Narouie, B., Ghasemi-Rad, M. Evaluating the effects of ginger extract on knee pain, stiffness and difficulty in patients with knee osteoarthritis. Journal of Medicinal Plants Research 2011; 15: 3375-3379
- Zegels, B., Crozes, P., Uebelhart, D., Bruyere, O., Reginster, J. Y. Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study. Osteoarthritis & Cartilage 2013; 1: 22-7